3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine

C25H35N — CID 122644566

IUPAC3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine
SMILESC[C@H]1CC[C@@]2(C)C(CCC3C2CC[C@]2(C)C(c4cccnc4)=CCC32)C1
InChIInChI=1S/C25H35N/c1-17-10-12-24(2)19(15-17)6-7-20-22-9-8-21(18-5-4-14-26-16-18)25(22,3)13-11-23(20)24/h4-5,8,14,16-17,19-20,22-23H,6-7,9-13,15H2,1-3H3/t17-,19?,20?,22?,23?,24-,25+/m0/s1
InChIKeyDHZYEHSVZIAIMX-FPOPRQLCSA-N
MW349.56 g/mol
LogP6.75
Rot. Bonds1

About 3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine

3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine (PubChem CID 122644566) has the molecular formula C25H35N and a molecular weight of 349.56 g/mol. Its IUPAC name is 3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine.

Molecular Properties

Compound Name3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine
PubChem CID122644566
Molecular FormulaC25H35N
Molecular Weight349.56 g/mol
Exact Mass349.28
IUPAC Name3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine
SMILESC[C@H]1CC[C@@]2(C)C(CCC3C2CC[C@]2(C)C(c4cccnc4)=CCC32)C1
InChIInChI=1S/C25H35N/c1-17-10-12-24(2)19(15-17)6-7-20-22-9-8-21(18-5-4-14-26-16-18)25(22,3)13-11-23(20)24/h4-5,8,14,16-17,19-20,22-23H,6-7,9-13,15H2,1-3H3/t17-,19?,20?,22?,23?,24-,25+/m0/s1
InChIKeyDHZYEHSVZIAIMX-FPOPRQLCSA-N
XLogP6.75
TPSA12.89 Ų
H-Bond Donors
H-Bond Acceptors1
Rotatable Bonds1
Heavy Atoms26
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500349.56
LogP ≤ 56.75
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 101

Analyze 3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine?
The IUPAC name of 3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine (CID 122644566) is 3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine.
What is the SMILES notation for 3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine?
The canonical SMILES for 3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine is C[C@H]1CC[C@@]2(C)C(CCC3C2CC[C@]2(C)C(c4cccnc4)=CCC32)C1.
What is the InChIKey of 3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine?
The InChIKey is DHZYEHSVZIAIMX-FPOPRQLCSA-N. The full InChI is InChI=1S/C25H35N/c1-17-10-12-24(2)19(15-17)6-7-20-22-9-8-21(18-5-4-14-26-16-18)25(22,3)13-11-23(20)24/h4-5,8,14,16-17,19-20,22-23H,6-7,9-13,15H2,1-3H3/t17-,19?,20?,22?,23?,24-,25+/m0/s1.
What are the key properties of 3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine?
3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine has a molecular weight of 349.56 g/mol, XLogP of 6.75, 1 rotatable bonds, 0 hydrogen bond donors, and 1 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(3S,10S,13S)-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine is sourced from PubChem (CID 122644566), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).